FDA approves Novartis Afinitor to treat advanced breast cancer – Pharmaceutical Business Review
FDA approves Novartis Afinitor to treat advanced breast cancerPharmaceutical Business ReviewNovartis has won FDA approval for Afinitor (everolimus) tablets for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative…
